The “first-in-patient” drug trial that addresses social withdrawal and challenging behaviours in the fragile X syndrome may…
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai Drug development
Menampilkan 101 - 107 dari 107 artikel
A new drug compound has successfully cured malaria in mice models, according to University of Cape Town (UCT) researchers…
The HIV drug “abacavir” has been found to induce a dangerous allergic reaction in patients with the HLA-B*5701 gene. The…
Disease-controlling drugs can now be absorbed into the body more efficiently and without food. Using nanotechnology, the…
The 2008 global financial crisis and an impending “patent cliff” have had a profound impact on the profitability of the pharmaceutical industry – they have made it change how it works. So, to maintain…
When people think about taking a new drug that can enhance who they are, or consider giving it to their child, their most immediate and appropriate concern centres on the potential health dangers. While…
Groundbreaking research linking an immune protein to the debilitating condition of virus-induced arthritis and viral exacerbation…
Kontributor teratas
-
Prof. Institute for Molecular Bioscience, The University of Queensland
-
Assistant Professor of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus
-
Associate Professor of History, University of Wollongong
-
Biostatistician, The University of Melbourne
-
Professor of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus
-
Dean of the College of Science, Professor of Biochemistry, Rochester Institute of Technology
-
Senior Lecturer Biostatistics and Data Management, The University of Queensland
-
Professor of Neuroscience, Lancaster University
-
Professor, UNSW Sydney
-
Joel Lexchin adalah Sahabat The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Associate Professor of Biostatistics, Murdoch Children's Research Institute
-
Director of Natural Product Discovery Core; Assistant Professor of Medicinal Chemistry, University of Michigan
-
Molecular and Clinical Pharmacology, University of Liverpool
-
Researcher, L’Université d’Ottawa/University of Ottawa
-
Executive General Manager Commercialisation and Research Contracts, Baker Heart and Diabetes Institute
